Startup Valuation Statistics by Stage
Startup valuation statistics by stage for 2026, covering pre-seed, seed, Series A, Series B, late-stage, AI premiums, regional gaps, founder type, and revenue multiples.
TL;DR: Startup valuation statistics by stage in 2026 show a market where valuations are rising for the strongest companies while the bar to qualify for those valuations is also rising. Carta reported that median post-money valuations reached $24 million at seed and $78.7 million at Series A in Q4 2025. Equidam put the Q1 2026 global pre-seed median valuation at $5.87 million, with the United States at $7.64 million and Europe at $3.48 million. Cooley showed late-stage inflation at the top, with Series D and later median pre-money valuation rising to $2.5 billion. The founder takeaway is simple: a higher valuation is useful only when the business can grow into it without losing control, credibility, or options.
Startup valuation statistics by stage are useful only when founders understand what the number is pricing. A $5 million pre-seed valuation, a $24 million seed post-money valuation, a $78.7 million Series A post-money valuation, and a $2.5 billion late-stage valuation do not describe the same type of company.
They describe different proof thresholds.
The 2026 valuation market is split. Strong AI, cloud, infrastructure, and category-leading companies can still command aggressive prices. Ordinary venture-backed startups face tighter proof standards, longer gaps between rounds, and investors who want more evidence before pricing the next step-up. Bootstrapped founders should read startup valuation benchmarks as negotiation context, not as a fantasy scoreboard.
Use this page with Mean CEO’s research on startup funding statistics by stage, pre-seed funding statistics, seed funding statistics, Series A funding statistics, startup down round statistics, startup runway statistics, and startup burn rate statistics.
Most Citeable Stats
Carta reported that median post-money valuation reached $24 million at seed in Q4 2025, up from $18 million one year earlier and $16 million two years earlier.
Carta reported that median Series A post-money valuation reached $78.7 million in Q4 2025, up 37% year over year from $57.5 million.
Equidam’s Q1 2026 dataset of 3,000-plus pre-seed valuations showed a $5.87 million global median valuation and a $0.67 million median capital requirement.
Equidam reported that Q1 2026 U.S. pre-seed median valuation was $7.64 million, while Europe’s median was $3.48 million.
Cooley reported that Series D and later median pre-money valuation rose from $1 billion in Q4 2025 to $2.5 billion in Q1 2026.
Cooley reported that Series B median pre-money valuation fell from $195 million in Q4 2025 to $165 million in Q1 2026, even as several other stages moved up.
Carta found that in 2025, median AI startup valuations were 38% higher at Series A and 193% higher at Series E+ than non-AI valuations.
SaaS Capital put its public SaaS index at 7.0 times current run-rate annualized revenue, with predicted private multiples of 4.8x for bootstrapped SaaS and 5.3x for equity-backed SaaS.
Key Statistics
Carta said the median post-money valuation at seed reached a new all-time high of $24 million in Q4 2025, with 25th and 75th percentile values also moving up.
Carta said the median Series A post-money valuation climbed to $78.7 million in Q4 2025, while early-stage dilution stayed around 19% to 20%.
Carta’s Q1 2025 report showed a $16 million median pre-money valuation for new seed rounds, about 18% higher than one year earlier.
Carta’s Q1 2025 report showed a $48 million median pre-money valuation for Series A rounds, up 9% year over year.
Carta’s 2025 pre-seed review reported $10.4 billion across 50,316 SAFEs and convertible notes for U.S. startups on Carta.
Carta said median post-money SAFE valuation caps hovered around $10 million for $250,000 to $1 million rounds and $15 million for $1 million to $2.5 million rounds.
Equidam reported that Q1 2026 median pre-seed capital requirements were $0.67 million, down from $0.80 million in H2 2025.
Equidam estimated Q1 2026 implied median pre-seed dilution at 10.2%, based on median capital divided by valuation plus capital.
Cooley reported that 86% of Q1 2026 deals were up rounds, while down rounds fell to 11.4%.
Cooley said the share of deals with pre-money valuations above $100 million increased from 40% in Q4 2025 to 42% in Q1 2026.
PitchBook and NVCA reported $267.2 billion in U.S. VC deal value in Q1 2026, but said the number would fall 73.2% without the five largest deals.
KPMG’s Q1 2026 Venture Pulse put U.S. VC investment at $267.2 billion across 3,336 deals, driven by four $10 billion-plus AI megadeals.
Bessemer’s 2025 Cloud 100 Benchmarks Report said the Cloud 100 cohort surpassed $1 trillion in aggregate value for the first time in the list’s 10-year history.
Forbes reported that AI companies represented 42% of total Cloud 100 value in 2025, up from 21% in 2024.
PitchBook’s female founders dashboard said U.S. companies founded or co-founded by women have received a smaller share of total deals in recent years while continuing to grow their share of capital raised.
Startup Valuation Snapshot by Stage
MeanCEO Index: Valuation Quality by Stage
The MeanCEO Index scores each valuation stage from 1 to 10 through Mean CEO’s operator lens. It does not reward the highest valuation automatically. It weighs founder control, proof quality, capital efficiency, dilution risk, next-round pressure, and how useful the valuation is for a bootstrapped or capital-efficient founder.
What Startup Valuation Really Prices
Startup valuation is not a moral judgment on the founder. It is the price investors agree to pay for ownership under uncertainty.
At pre-seed, the uncertainty is almost everything: team, timing, product, customer, distribution, and category. At seed, the valuation should start reflecting traction and buyer evidence. At Series A, the valuation should price repeatability. At Series B and later, the price should increasingly reflect operating quality, growth efficiency, and exit potential.
That is why valuation benchmarks can be dangerous when used lazily. A founder who sees a $24 million median seed post-money valuation and assumes their own company deserves the same number is skipping the hard part: proof.
For a bootstrapped founder, the better use of valuation statistics is tactical:
- Use benchmarks to understand the negotiation zone.
- Use customer revenue to defend the number.
- Use dilution math to protect ownership.
- Use stage data to avoid raising at a price the next round cannot defend.
- Use regional and sector comparisons to avoid copying Silicon Valley pricing in a market that will not support it.
The founder’s real job is not to maximize the current valuation in isolation. The job is to keep the company fundable, sellable, and operable.
Mean CEO Take
I like valuation data because it exposes startup vanity quickly.
Founders love high valuations when the announcement goes out. Then the same founders discover that a high valuation becomes a bill. It asks for stronger revenue, cleaner retention, faster growth, sharper hiring, better reporting, and a future investor willing to pay even more.
For bootstrappers, especially women and European founders who often get less room for narrative pricing, valuation should be treated as a tool for ownership. A fair valuation with strong customer proof beats a glamorous valuation that forces the company into a down round later.
If you are raising, know the benchmark. Then ask a better operating question: what evidence makes this valuation believable?
If the answer is vague, lower the spend, sell sooner, and create proof before the market creates discipline for you.
Pre-Seed Startup Valuations
Pre-seed valuation data is messy because many companies have no full product, no steady revenue, and no institutional history. That is why pre-seed pricing often depends on founder quality, problem pain, prototype quality, market timing, angel appetite, and geography.
Equidam’s Q1 2026 pre-seed dataset is useful because it separates the global median from regional medians. The global median valuation was $5.87 million. The U.S. median was $7.64 million. Europe’s median was $3.48 million.
That difference matters for European bootstrappers. If a founder in Amsterdam, Berlin, Lisbon, or Warsaw copies U.S. pre-seed pricing without U.S. investor demand, they can make the round harder and set themselves up for a painful next negotiation.
Carta’s pre-seed SAFE data gives a second lens. In 2025, U.S. startups on Carta raised $10.4 billion across 50,316 SAFEs and convertible notes. Median post-money SAFE caps hovered around $10 million for $250,000 to $1 million rounds and $15 million for $1 million to $2.5 million rounds.
The founder move is practical: treat pre-seed valuation as a runway and dilution equation. If the round does not buy a clear proof point, the valuation is theatre with legal documents attached.
Seed Startup Valuations
Seed valuations moved up in 2025 for companies that cleared the investor bar.
Carta reported that the median seed post-money valuation reached $24 million in Q4 2025, up from $18 million a year earlier and $16 million two years earlier. Carta also said round sizes were trending up while dilution at seed and Series A stayed near 19% to 20%.
That combination tells founders something important. Investors may pay higher prices, but they still expect meaningful ownership. Higher valuations are happening alongside larger rounds and stronger expectations.
Seed valuation now often prices:
- A clear buyer segment.
- Early revenue or strong usage quality.
- Evidence that distribution can work.
- A credible technical or market edge.
- A team that can move fast without over-hiring.
Seed is where founders can create the most leverage before heavy governance arrives. It is also where a founder can create the first valuation trap. A seed round priced too high can make the Series A harder if revenue, retention, and growth quality lag behind the story.
Series A Startup Valuations
Series A valuation is the repeatability test.
Carta’s Q4 2025 data showed a $78.7 million median Series A post-money valuation, up 37% year over year. Earlier in the year, Carta’s Q1 2025 report showed a $48 million median Series A pre-money valuation, up 9% year over year.
The numbers sound founder-friendly. The reality is more selective. Investors have been paying up for companies with stronger proof, especially AI or AI-enabled companies, while weaker companies face tougher terms or no round.
Series A valuation usually prices product-market fit signals, revenue growth, retention or repeat purchase behavior, sales cycle clarity, gross margin, founder ability to hire and manage, and a credible route from early traction to scale.
For capital-efficient founders, Series A should accelerate something already working. If the founder needs the Series A to find the customer, the valuation is probably pretending.
Series B, Series C, and Late-Stage Valuations
Series B and later valuations are more sensitive to operating discipline.
Cooley’s Q1 2026 report showed Series B median pre-money valuation falling from $195 million in Q4 2025 to $165 million in Q1 2026. In the same report, Series D and later median pre-money valuation rose from $1 billion to $2.5 billion.
That split shows the 2026 valuation market clearly. Some later-stage companies, especially those with large AI narratives or infrastructure-scale potential, can command very large valuations. Mid-stage companies still need strong metrics and patience.
Series B and Series C valuations usually price revenue scale and growth quality, sales efficiency, net revenue retention or expansion quality, gross margin, leadership depth, market expansion potential, and exit optionality.
Late-stage valuations add another layer: public-market comparables, secondary demand, IPO timing, strategic buyer appetite, and investor liquidity expectations.
Founders should watch late-stage valuation data because it affects market mood. They should not use it as a planning benchmark for an early company.
Valuation Data by Geography
Geography still affects startup valuations because investor density, exit history, local competition, and capital depth are uneven.
The European lesson is direct. Lower early-stage valuation can be an advantage if the founder uses it to preserve realistic expectations and avoid a future down round. It becomes a disadvantage when investors use the region as an excuse to underprice real technical ambition.
Valuation Data by Sector
Sector affects valuation because investors price growth rate, margin, defensibility, capital intensity, and exit potential differently.
AI is the obvious valuation premium in 2026. The harder founder question is whether the AI label reflects a defensible product, or just a fundraising costume.
Valuation Data by Revenue Band
Revenue does not explain every startup valuation, especially at pre-seed and seed. By Series A and later, revenue quality matters more.
For SaaS, revenue multiples help translate valuation into operating reality. SaaS Capital’s 2025 analysis put its SaaS Capital Index at 7.0 times current run-rate annualized revenue. Its model predicted private SaaS valuation multiples of 4.8x for bootstrapped companies and 5.3x for equity-backed companies.
For founders, revenue bands should be used with honesty. $50,000 in messy services revenue, $50,000 in repeatable product revenue, and $50,000 in annualized usage-based AI revenue are not the same valuation signal.
Valuation Data by Founder Type
Founder type affects valuation indirectly through access, pattern matching, investor networks, sector concentration, and bias.
PitchBook’s female founders dashboard, updated April 6, 2026 with data through March 31, 2026, reported that U.S. companies founded or co-founded by women have recently received a smaller share of total deals while increasing their share of capital raised. PitchBook’s 2025 All In report focused on U.S. VC-backed companies founded by women and highlighted a market shaped by AI megadeals and capital concentration.
Inc. summarized PitchBook data with a sharp unicorn signal: in 2025, the U.S. minted 124 new unicorns, but only 20 had at least one female founder and none were founded by all-female teams.
For female founders, valuation strategy needs more discipline because the market often gives less room for vague promise. That is unfair. It is also the reason practical proof matters: paying customers, clean margins, technical evidence, distribution data, and strong documentation make the valuation harder to dismiss.
How To Use Valuation Benchmarks Before Raising
Before accepting a valuation, founders should model the next round.
- Current valuation: pre-money, post-money, SAFE cap, or implied value.
- Current dilution: percentage sold now and expected converted dilution later.
- Next-round target: what valuation the company must justify in 12 to 24 months.
- Proof gap: revenue, retention, growth, technical milestone, regulatory milestone, or distribution milestone needed.
- Cash cost: how much capital is required to create that proof.
- Time cost: how many months the proof will take.
- Downside path: what happens if the next round is flat or down.
- No-round path: how the company keeps moving through customer revenue.
This is where bootstrappers have an edge. If customers finance the next proof point, the founder can negotiate with options. If investors are the only oxygen source, the valuation number owns the founder.
Valuation Traps Founders Should Avoid
The first trap is confusing post-money valuation with founder wealth. A $24 million post-money seed valuation does not put $24 million in the founder’s bank account. It creates a priced expectation.
The second trap is ignoring SAFE stacks. Several small pre-seed instruments can convert into larger dilution than the founder expected, especially when caps, discounts, and pro-rata rights compound.
The third trap is copying AI valuations without AI economics. AI can increase productivity and market appetite. It can also increase compute costs, competition, and customer skepticism.
The fourth trap is raising at a valuation that requires a perfect next round. If the company needs flawless growth, a friendly market, a high multiple, and a generous lead investor to avoid pain, the current valuation is fragile.
The fifth trap is using U.S. benchmarks in Europe without checking local investor appetite. Europe can build serious companies. European founders still need to understand the local pricing environment, especially at pre-seed and seed.
Methodology
This article compares public and semi-public startup valuation datasets available as of May 7, 2026. It uses Carta for U.S. private-company stage benchmarks, SAFE caps, AI premiums, SaaS industry signals, and early-stage valuation movement. It uses Cooley for reported venture financing terms and median pre-money valuation movement in Q1 2026. It uses PitchBook/NVCA, KPMG, and Crunchbase-style market context for capital concentration and broader VC deal value. It uses Equidam for global and regional pre-seed valuation benchmarks. It uses SaaS Capital, Bessemer, Forbes, Atomico, Dealroom, and PitchBook female-founder research for revenue, sector, geography, and founder-type context.
The datasets are not directly interchangeable. Carta data reflects companies on Carta. Cooley data reflects venture financings handled by Cooley. Equidam data reflects valuations completed on Equidam. PitchBook, NVCA, KPMG, and Bessemer use their own definitions and data capture methods. This article keeps provider names, periods, geography, and definitions attached to the numbers so founders do not merge incompatible benchmarks.
Valuation figures can be pre-money, post-money, SAFE caps, enterprise value, or revenue multiples. The article labels the type where the source provides it.
Definitions
Startup valuation means the price assigned to a company in a financing, sale, secondary transaction, or valuation model. In venture fundraising, founders usually discuss pre-money valuation, post-money valuation, or SAFE valuation cap.
Pre-money valuation means the company’s value before new investment enters the company.
Post-money valuation means the company’s value after the new investment is included.
SAFE valuation cap means the maximum valuation used to convert a SAFE into equity during a future priced round, subject to the SAFE terms.
Pre-seed means the earliest outside funding stage, often before a full product or repeatable revenue.
Seed means early capital used to move from validation toward stronger product, customer, revenue, and distribution proof.
Series A means a major institutional round that usually expects product-market fit signals and early repeatability.
Series B means expansion capital for a company with stronger revenue, team, product, and go-to-market evidence.
Series C and later means growth capital for companies with scale, expansion plans, strategic optionality, or a path toward liquidity.
Down round means a financing round priced below the valuation of a previous priced round.
Flat round means a financing round priced around the previous valuation.
Up round means a financing round priced above the previous valuation.
Revenue multiple means valuation divided by annual revenue, annual recurring revenue, or run-rate annualized revenue, depending on the source.
FAQ
What is a good startup valuation by stage in 2026?
A good startup valuation in 2026 is one the company can grow into. Equidam’s Q1 2026 global pre-seed median was $5.87 million, Carta’s Q4 2025 median seed post-money valuation was $24 million, and Carta’s Q4 2025 median Series A post-money valuation was $78.7 million. Those benchmarks are useful context, but the right valuation depends on proof, geography, sector, revenue quality, dilution, and next-round risk.
What is the average pre-seed valuation in 2026?
Equidam reported a Q1 2026 global pre-seed median valuation of $5.87 million. The U.S. median was $7.64 million, while Europe’s median was $3.48 million. Carta’s 2025 U.S. pre-seed SAFE data showed common post-money caps around $10 million for $250,000 to $1 million rounds and $15 million for $1 million to $2.5 million rounds.
What is the median seed valuation in 2026?
Carta reported that the median seed post-money valuation reached $24 million in Q4 2025. That is the strongest recent Carta benchmark for seed pricing entering 2026. Founders should still separate post-money valuation, pre-money valuation, round size, dilution, and SAFE conversion effects.
What is the median Series A valuation in 2026?
Carta reported a $78.7 million median Series A post-money valuation in Q4 2025. Earlier in 2025, Carta reported a $48 million median Series A pre-money valuation in Q1 2025. The difference matters because pre-money and post-money figures are not the same.
Why are AI startup valuations higher?
AI startup valuations are higher because investors are pricing growth potential, software productivity, data advantages, infrastructure demand, and category leadership. Carta found that AI startups had a 38% median valuation premium at Series A and a 193% premium at Series E+ in 2025. That premium is not a guarantee that every AI startup deserves a higher valuation.
How much dilution should founders expect?
Dilution varies by stage, round size, instrument, and negotiation leverage. Carta’s record-setting valuation analysis said seed and Series A dilution medians remained around 19% to 20% while valuations and round sizes rose. Equidam estimated Q1 2026 median pre-seed implied dilution at 10.2% in its dataset.
Are European startup valuations lower than U.S. valuations?
At pre-seed, Equidam’s Q1 2026 data showed a clear gap: $7.64 million median valuation in the United States versus $3.48 million in Europe. European founders should account for investor density, capital depth, local comparables, and cross-border fundraising access before copying U.S. pricing.
Should bootstrapped founders care about startup valuation statistics?
Yes, but they should use valuation statistics differently. A bootstrapped founder can use benchmarks for negotiation, equity planning, grant strategy, secondary planning, and acquisition conversations. The main goal is preserving ownership while creating proof through customers.
What causes a startup down round?
A down round can happen when a company fails to justify its previous valuation, market multiples fall, growth slows, burn is too high, revenue quality is weak, or investors demand tougher terms. Mean CEO’s article on startup down round statistics tracks that risk in more detail.
How should founders calculate a fair valuation?
Start with the relevant stage benchmark, then adjust for revenue quality, growth, retention, market size, sector premium, geography, gross margin, technical defensibility, founder leverage, and dilution. Then test whether the company can justify the next valuation step within its runway.
